Your Complete Guide to Global Clinical Research and GCP Compliance
Case Studies: Central vs. Local Lab Strategies That Improved Turnaround Time and Data Quality Case Studies: Central vs. Local Lab Strategies That Improved Turnaround Time and Data Quality The landscape of clinical research is continuously evolving, with trial management processes becoming more precise yet complex. This article focuses on lab strategies within clinical trials, specifically…
KRIs, KPIs and Dashboards to Monitor Central vs. Local Lab Strategies Performance KRIs, KPIs and Dashboards to Monitor Central vs. Local Lab Strategies Performance Understanding Key Performance Indicators (KPIs) and Key Risk Indicators (KRIs) in Clinical Trials In the landscape of clinical research management, the implementation of Key Performance Indicators (KPIs) and Key Risk Indicators…
Read More “KRIs, KPIs and Dashboards to Monitor Central vs. Local Lab Strategies Performance” »
Quality Controls and SOPs to Standardize Central vs. Local Lab Strategies Across Sites and Labs Quality Controls and SOPs to Standardize Central vs. Local Lab Strategies Across Sites and Labs In the ever-evolving landscape of clinical research, particularly in clinical trials such as those conducted by Gilead, the standardization of laboratory strategies is critical. This…
Digital Tools, LIMS and Automation to Streamline Central vs. Local Lab Strategies In the realm of clinical trial management, efficient laboratory and sample management is paramount to ensure compliance with ICH-GCP standards and regulatory requirements. This article serves as a comprehensive guide on utilizing digital tools, Laboratory Information Management Systems (LIMS), and automation to streamline…
Read More “Digital Tools, LIMS and Automation to Streamline Central vs. Local Lab Strategies” »
Future Trends: Digital, Decentralized and Omics-Driven Central vs. Local Lab Strategies In the last few years, the clinical trial landscape has undergone a significant transformation, propelled by the integration of digital technologies and data-driven methodologies. This article provides a comprehensive, step-by-step guide for clinical operations, regulatory affairs, and medical affairs professionals on the current and…
How Central vs. Local Lab Strategies Supports Regulatory Submissions and Inspection Readiness How Central vs. Local Lab Strategies Supports Regulatory Submissions and Inspection Readiness In the realm of clinical trials, the choice between central and local lab strategies plays a pivotal role not only in data quality but also in ensuring compliance with regulatory requirements….
Risk Management and Contingency Planning for Central vs. Local Lab Strategies Failures Risk Management and Contingency Planning for Central vs. Local Lab Strategies Failures In the realm of clinical trials, risk management and contingency planning are critical components that ensure the success and integrity of the study. This is especially true when considering the varying…
Read More “Risk Management and Contingency Planning for Central vs. Local Lab Strategies Failures” »
Training Site and Lab Staff to Execute Central vs. Local Lab Strategies Reliably As the realm of clinical trials continues to evolve, the imperative of ensuring that site and laboratory staff are trained to execute both central and local lab strategies cannot be overstated. This tutorial provides a comprehensive, step-by-step approach to training site and…
Read More “Training Site and Lab Staff to Execute Central vs. Local Lab Strategies Reliably” »
Vendor and Central Lab Oversight Models to Strengthen Central vs. Local Lab Strategies Vendor and Central Lab Oversight Models to Strengthen Central vs. Local Lab Strategies In today’s complex landscape of clinical trials, the roles of central and local laboratories are critical. The choice between using a central lab versus local labs can significantly impact…
Read More “Vendor and Central Lab Oversight Models to Strengthen Central vs. Local Lab Strategies” »
Aligning Sample Handling, Chain of Custody & Biosafety With Protocol, PK/PD and Biomarker Strategies Aligning Sample Handling, Chain of Custody & Biosafety With Protocol, PK/PD and Biomarker Strategies In the context of clinical trials, the integrity and reliability of results are paramount, which makes an understanding of sample handling, chain of custody, and biosafety essential….
Don’t leave empty-handed. Watch practical GMP scenarios, inspection lessons, deviations, CAPA thinking, and real compliance insights on our YouTube channel. One click now can save you hours later.